Please login to the form below

Not currently logged in
Email:
Password:

REGN-COV2

This page shows the latest REGN-COV2 news and features for those working in and with pharma, biotech and healthcare.

FDA grants emergency use for Lilly’s COVID-19 antibody drug combination

FDA grants emergency use for Lilly’s COVID-19 antibody drug combination

On a key clinical endpoint, REGN-COV2 treatment reduced COVID-19-related medical visits by 57% until day 29. ... Treatment with REGN-COV2 also reduced COVID-19-related medical visits by 72% in patients with one or more risk factors.

Latest news

More from news
Approximately 6 fully matching, plus 10 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Virtual MSL/Sales training programs and events
Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....
Omnichannel strategies to revolutionize the healthcare professional experience
Fishawack Health’s omnichannel experts unite to reveal how medical and commercial teams can build more meaningful experiences for healthcare professionals. They discuss the opportunities of omnichannel and explore how the...